首页> 美国卫生研究院文献>International Journal of Molecular Sciences >Immunobiology of Newcastle Disease Virus and Its Use for Prophylactic Vaccination in Poultry and as Adjuvant for Therapeutic Vaccination in Cancer Patients
【2h】

Immunobiology of Newcastle Disease Virus and Its Use for Prophylactic Vaccination in Poultry and as Adjuvant for Therapeutic Vaccination in Cancer Patients

机译:新城疫病毒的免疫生物学及其在禽类中的预防性疫苗接种以及作为癌症患者治疗性疫苗佐剂的用途

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Newcastle disease (ND) is one of the most important diseases of poultry worldwide. In the last decades, molecular research has gained a lot of new information about its causative agent, newcastle disease virus (NDV). In poultry industry, certain strains of NDV have been used for preventive vaccination for more than 60 years. NDV has also been applied to cancer patients with beneficial effects for about 50 years, but this is less well known. The molecular basis for these differential effects of NDV in birds and man have been elucidated in the last decades and are explained in this review. The anti-neoplastic and immune-stimulatory properties in non-permissive hosts such as mouse and man have to do with the strong type I interferon responses induced in these foreign species. Additionally, NDV has the potential to break various types of tumor resistances and also to affect liver fibrosis. A main section is devoted to the benefits of clinical application of NDV and NDV-based vaccines to cancer patients. Reverse genetics technology allowed developing NDV into a vector suitable for gene therapy. Examples will be provided in which genetically engineered NDV is being used successfully as vector against new emerging viruses.
机译:新城疫(ND)是世界上最重要的家禽疾病之一。在过去的几十年中,分子研究获得了有关其病原体新城疫病毒(NDV)的许多新信息。在家禽业中,NDV的某些菌株已用于预防接种超过60年。 NDV也已被用于具有有益效果的癌症患者约50年,但这鲜为人知。在过去的几十年中,已经阐明了NDV对鸟类和人的这些不同作用的分子基础,并在本综述中进行了解释。非宽松宿主(如小鼠和人)的抗肿瘤和免疫刺激特性与这些外来物种中诱导的强烈的I型干扰素反应有关。此外,NDV可能会破​​坏各种类型的肿瘤抵抗力,并可能影响肝纤维化。主要部分专门介绍了NDV和基于NDV的疫苗在癌症患者中的临床应用益处。逆向遗传学技术使NDV发展成为适合基因治疗的载体。将提供实例,其中基因工程化的NDV被成功用作抗新出现的病毒的载体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号